[HTML][HTML] Improved overall survival after implementation of targeted therapy for patients with metastatic renal cell carcinoma: results from the Danish Renal Cancer …

AV Soerensen, F Donskov, GG Hermann… - European Journal of …, 2014 - Elsevier
Aim To evaluate the implementation of targeted therapy on overall survival (OS) in a
complete national cohort of patients with metastatic renal cell carcinoma (mRCC). Methods …

[PDF][PDF] Improved overall survival after implementation of targeted therapy for patients with metastatic renal cell carcinoma: Results from the Danish Renal Cancer …

AV Soerensen, F Donskov, GG Hermann… - European Journal of …, 2014 - scholar.archive.org
Aim: To evaluate the implementation of targeted therapy on overall survival (OS) in a
complete national cohort of patients with metastatic renal cell carcinoma (mRCC). Methods …

[PDF][PDF] Improved overall survival after implementation of targeted therapy for patients with metastatic renal cell carcinoma: Results from the Danish Renal Cancer …

AV Soerensen, F Donskov, GG Hermann… - European Journal of …, 2014 - cyberleninka.org
Aim: To evaluate the implementation of targeted therapy on overall survival (OS) in a
complete national cohort of patients with metastatic renal cell carcinoma (mRCC). Methods …

[PDF][PDF] Improved overall survival after implementation of targeted therapy for patients with metastatic renal cell carcinoma: Results from the Danish Renal Cancer …

AV Soerensen, F Donskov, GG Hermann, NV Jensen… - 2013 - researchgate.net
Aim: To evaluate the implementation of targeted therapy on overall survival (OS) in a
complete national cohort of patients with metastatic renal cell carcinoma (mRCC). Methods …

Improved overall survival after implementation of targeted therapy for patients with metastatic renal cell carcinoma: results from the Danish Renal Cancer Group …

AV Soerensen, F Donskov, GG Hermann… - European Journal of …, 2013 - europepmc.org
Aim To evaluate the implementation of targeted therapy on overall survival (OS) in a
complete national cohort of patients with metastatic renal cell carcinoma (mRCC). Methods …

[引用][C] Improved overall survival after implementation of targeted therapy for patients with metastatic renal cell carcinoma: Results from the Danish Renal Cancer …

AV SOERENSEN, F DONSKOV… - European journal of …, 2014 - pascal-francis.inist.fr
Improved overall survival after implementation of targeted therapy for patients with metastatic
renal cell carcinoma: Results from the Danish Renal Cancer Group (DARENCA) study-2 …

Improved overall survival after implementation of targeted therapy for patients with metastatic renal cell carcinoma: Results from the Danish Renal Cancer Group …

AV Sørensen, F Donskov, GG Hermann… - European Journal of …, 2014 - orbit.dtu.dk
AbstractAim To evaluate the implementation of targeted therapy on overall survival (OS) in a
complete national cohort of patients with metastatic renal cell carcinoma (mRCC). Methods …

Improved overall survival after implementation of targeted therapy for patients with metastatic renal cell carcinoma: Results from the Danish Renal Cancer Group …

AV Soerensen, F Donskov, GG Hermann… - European Journal of …, 2014 - ejcancer.com
Aim To evaluate the implementation of targeted therapy on overall survival (OS) in a
complete national cohort of patients with metastatic renal cell carcinoma (mRCC). Methods …

Improved overall survival after implementation of targeted therapy for patients with metastatic renal cell carcinoma: results from the Danish Renal Cancer Group …

AV Sørensen, F Donskov, GG Hermann… - European Journal of …, 2014 - pure.au.dk
AIM: To evaluate the implementation of targeted therapy on overall survival (OS) in a
complete national cohort of patients with metastatic renal cell carcinoma (mRCC) …

Improved overall survival after implementation of targeted therapy for patients with metastatic renal cell carcinoma: Results from the Danish Renal Cancer Group …

AV Soerensen, F Donskov, GG Hermann… - European Journal of …, 2014 - infona.pl
To evaluate the implementation of targeted therapy on overall survival (OS) in a complete
national cohort of patients with metastatic renal cell carcinoma (mRCC). All Danish patients …